Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

Subjects:

Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

Subjects:

Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

Subjects:

Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

Subjects:

Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

Subjects:

Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

Subjects:

Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

Subjects:

Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

Subjects:

Native and polymerized A1AT <i>ex-vivo</i> effect on CS-exposed AM efferocytosis. by Karina A. Serban (553981)

MMP-2 production is decreased following ALK5 inhibition. by Rebecca A. Scott (488956)

Decreased exploratory activity in the second day trial in offspring of exercised mothers indicates habituation. by Sérgio Gomes da Silva (846060)

“…For both the 5- and 10-min investigation periods, a significant decrease in peripheral locomotion was detected in the EX group between the first and second trial (*p < 0.05; one-way ANOVA with repeated measures; Bonferroni post hoc). …”

Atorvastatin does not affect extent of atherosclerosis, lesion cell composition or lesion inflammation Female <i>Apoe</i>^<i>-/-</i> mice were first fed Western diet to i... by Matias Ekstrand (758818)

Ocular development and marker expression in <i>pitx2^ex4/5</i> morphants. by Yi Liu (36759)

“…Please note expression of <i>pax6a</i> in the developing retina of the control and morphant embryos (arrowheads in <b>A–D</b>); similar <i>pitx3</i> expression in the developing lens in 48–72-hpf control and morphant embryos (arrowheads in <b>E–H</b>; abnormally developing pharyngeal arches and oral cavity in 48–72-hpf embryos are marked with arrows); reduced expression of <i>dkk2</i> in the anterior segment of the <i>pitx2</i> morphants (arrowheads in <b>I–L</b>); decreased/absent expression of corneal keratan sulfate proteoglycan (CKS) in the developing morphant corneas (red fluorescence, arrowheads in <b>M–P</b>) but similar expression of crystallins αA (green fluorescence, arrows in <b>M, N</b>) and βB1 (green fluorescence, arrows in <b>O, P</b>) in control and morphant lenses; and a decreased/absent expression of the <i>Tg(gsnl1:gfp)</i> transgene in the developing iridocorneal structures of <i>pitx2^ex4/5</i> morphants (arrowheads in <b>R, T</b>) in comparison to control embryos (<b>Q, S</b>). …”

ZfpA overexpression decreases voriconazole efficacy <i>in vitro</i> and during infection. by Taylor J. Schoen (15383519)

Computational model of WDR neuron with ASIC1a channel parameters and a synaptic cleft acidification system. by Magda Chafaï (15307098)

Subjects:

Circulatory Responses to Asphyxia Differ if the Asphyxia Occurs <i>In Utero</i> or <i>Ex Utero</i> in Near-Term Lambs by Kristina S. Sobotka (659908)

“…Heart rates in <i>in utero</i> lambs rapidly decreased, while heart rates in <i>ex utero</i> lambs initially increased following cord occlusion (for ∼1.5 min) before they started to decrease. …”

Stress and stiffness (mean ± SD) in ex-vivo indentation test. by Hendricus Nijland (15198278)

Oleic acid supplementation enhances mycobacterial survival in cells wherein PRMT5 and NOTCH pathway activation is compromised. by Salik Miskat Borbora (9381455)

Subjects:

PDGF-BB-induced NR4A1 expression is decreased after treatment with the NF-κB inhibitor BAY11-7082. by Glenda Eger (636934)

A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activity by Regina Michelis (2889092)

“…In patients with abnormal C5, basal levels of sC5b-9 and C5a were increased while activities of the CP and of the CP C5-convertase, the immediate C5-upstream complex, were decreased compared to NC and to patients with normal C5. …”